オラジェニクスのニュース一覧

Oragenics, Inc. Announces Conversion of Preferred Shares and Elimination of Liquidation Preference

Oragenics12/16 13:00

Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More

Seeking Alpha11/18 13:09

オラジェニクス | 10-Q：Q3 2024 四半期報告書

SEC11/14 03:43

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

GlobeNewswire10/18 20:30

Oragenics Shares Are Trading Higher After the Company Provided a Corporate Update on Its 2024 Progress Including Developments of ONP-002, Its Lead Candidate for Concussions.

Benzinga10/09 21:14

Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation

Oragenics10/09 12:00

Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002

GlobeNewswire10/08 20:45

EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate

Benzinga10/08 20:30

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga09/25 22:42

Athira Pharma ATHA Phase 2/3 Data; Oragenics OGEN Offering

BioPharmCatalyst09/05 03:36

Top Midday Decliners

MT Newswires09/05 02:29

Sector Update: Health Care Stocks Retreat Wednesday Afternoon

MT Newswires09/05 01:54

Why Oragenics (OGEN) Stock Is Getting Hammered

Benzinga09/05 00:22

Oragenics, Inc. Announces Pricing of Public Offering

GlobeNewswire09/04 20:36

Nvidia Weighs Down Markets as US Futures Trend Lower in Wednesday's Premarket Session

MT Newswires09/04 20:09

Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Benzinga09/04 18:39

Oragenics Shares Are Trading Higher After the Company Announced the Filing Completion for Its ONP-002 Drug in Anticipation of Its Phase IIa Clinical Trail in Concussed Patients.

Benzinga08/21 20:48

EXCLUSIVE: Oragenics Tells Benzinga 'No Pharmaceutical Treatment Is Available for Concussion; Drug, ONP-002, Could Be First of Its Kind to Treat Concussion'

Benzinga08/21 20:30

EXCLUSIVE: Oragenics Tells Benzinga Co. Completes Spray Dry Drug Manufacturing And Intranasal Device Filling In Anticipation Of Phase IIa Clinical Trial In Concussed Patients

Benzinga08/21 20:30

Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients

Oragenics08/21 12:00